NasdaqCM:DMRABiotechs
Assessing Damora Therapeutics (DMRA) Valuation After Major Leadership Changes And Ongoing Equity Inducement Grants
Leadership shake up at Damora Therapeutics
Damora Therapeutics (DMRA) is entering a new phase, with Jennifer Jarrett set to become Chief Executive Officer and President on March 30, 2026, alongside several board changes and equity inducement grants.
See our latest analysis for Damora Therapeutics.
Damora Therapeutics’ latest leadership changes come after a choppy year, with a 30 day share price return of an 11.53% decline, a 90 day share price return of a 14.99% gain, and a very large 1 year...